V. Martínez Taboada

473 total citations
15 papers, 198 citations indexed

About

V. Martínez Taboada is a scholar working on Rheumatology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, V. Martínez Taboada has authored 15 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 6 papers in Pathology and Forensic Medicine and 6 papers in Physiology. Recurrent topics in V. Martínez Taboada's work include Salivary Gland Disorders and Functions (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). V. Martínez Taboada is often cited by papers focused on Salivary Gland Disorders and Functions (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). V. Martínez Taboada collaborates with scholars based in Spain, United Kingdom and United States. V. Martínez Taboada's co-authors include Axel Finckh, Andrea Rubbert‐Roth, J.E. Gottenberg, A. Andrianakos, Chiedzo Mpofu, Cecilia P. Chung, Paul Emery, Piercarlo Sarzi‐Puttini, Robert J. Moots and D. Choquette and has published in prestigious journals such as Annals of the Rheumatic Diseases, Rheumatology International and Biologics.

In The Last Decade

V. Martínez Taboada

14 papers receiving 190 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Martínez Taboada Spain 7 138 67 54 38 31 15 198
Mieke F. Pouw Netherlands 4 125 0.9× 143 2.1× 49 0.9× 65 1.7× 11 0.4× 6 285
A. Sellas Spain 10 193 1.4× 138 2.1× 56 1.0× 18 0.5× 13 0.4× 19 300
Aleksander Lenert United States 8 89 0.6× 111 1.7× 101 1.9× 24 0.6× 11 0.4× 20 249
J. Tébib France 8 190 1.4× 99 1.5× 50 0.9× 32 0.8× 7 0.2× 21 264
Bettina Bannert Switzerland 7 62 0.4× 35 0.5× 22 0.4× 19 0.5× 10 0.3× 13 158
À. Olivé Spain 7 103 0.7× 34 0.5× 20 0.4× 36 0.9× 7 0.2× 13 175
Víctor Martínez‐Taboada Spain 8 120 0.9× 41 0.6× 18 0.3× 14 0.4× 13 0.4× 8 195
William Ollier United Kingdom 5 156 1.1× 55 0.8× 50 0.9× 25 0.7× 7 0.2× 8 231
Aideen Hogan United Kingdom 8 89 0.6× 23 0.3× 24 0.4× 32 0.8× 21 0.7× 9 296
Tiziana Bertero Italy 7 189 1.4× 55 0.8× 138 2.6× 13 0.3× 32 1.0× 11 284

Countries citing papers authored by V. Martínez Taboada

Since Specialization
Citations

This map shows the geographic impact of V. Martínez Taboada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Martínez Taboada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Martínez Taboada more than expected).

Fields of papers citing papers by V. Martínez Taboada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Martínez Taboada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Martínez Taboada. The network helps show where V. Martínez Taboada may publish in the future.

Co-authorship network of co-authors of V. Martínez Taboada

This figure shows the co-authorship network connecting the top 25 collaborators of V. Martínez Taboada. A scholar is included among the top collaborators of V. Martínez Taboada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Martínez Taboada. V. Martínez Taboada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Calvo‐Alén, Jaime, et al.. (2022). TNF Inhibitors Exert a “Hidden” Beneficial Effect in the Cardiovascular Lipoprotein Profile of RA Patients. Biologics. Volume 16. 187–197. 4 indexed citations
2.
Castro, M. Fernández, Carlos Sánchez‐Piedra, José Luís Andreu, et al.. (2018). AB0524 How do we treat dryness in patients with primary sjÖgren's syndrome? a nationwide study in spain from the sjogrenser registry. Annals of the Rheumatic Diseases. 77. 1420–1420. 1 indexed citations
3.
Castro, M. Fernández, Carlos Sánchez‐Piedra, José Luís Andreu, et al.. (2018). Factors associated with severe dry eye in primary Sjögren’s syndrome diagnosed patients. Rheumatology International. 38(6). 1075–1082. 18 indexed citations
4.
Martínez‐López, Joaquín, Rafael Cáliz, Mercedes Freire, et al.. (2017). Recommendations for the Evaluation and Management of Patients With Rheumatic Autoimmune and Inflammatory Diseases During the Reproductive Age, Pregnancy, Postpartum and Breastfeeding. Reumatología Clínica (English Edition). 13(5). 264–281. 8 indexed citations
5.
Martínez‐López, Joaquín, Rafael Cáliz, Mercedes Freire, et al.. (2016). Recomendaciones sobre actuaciones a seguir durante la edad fértil, el embarazo, posparto y lactancia en pacientes con enfermedades reumáticas inflamatorias y autoinmunes. Reumatología Clínica. 13(5). 264–281. 14 indexed citations
6.
Castro, M. Fernández, José Luís Andreu, Carlos Sánchez‐Piedra, et al.. (2016). Sjögren SER: National registry of the Spanish Society of Rheumatology of patients with primary Sjögren syndrome: Objectives and methodology. Reumatología Clínica (English Edition). 12(4). 184–189. 5 indexed citations
7.
Castro, M. Fernández, José Luís Andreu, Carlos Sánchez‐Piedra, et al.. (2016). FRI0344 Extra-Glandular Manifestations of Primary Sjögren Syndrome Excluded from Disease Activity Indexes. Annals of the Rheumatic Diseases. 75. 559–559. 1 indexed citations
8.
Castro, M. Fernández, José Luís Andreu, Carlos Sánchez‐Piedra, et al.. (2015). SJÖGREN-SER: Registro nacional de pacientes con síndrome de Sjögren primario de la Sociedad Española de Reumatología: objetivos y metodología. Reumatología Clínica. 12(4). 184–189. 6 indexed citations
9.
Castro, M. Fernández, José Luís Andreu, V. Martínez Taboada, et al.. (2015). AB0597 Sjogrenser Cohort: Clinical and Epidemiological Features of Primary SjÖgren's Syndrome in Spanish Rheumathology Departments. Annals of the Rheumatic Diseases. 74. 1099–1099. 1 indexed citations
10.
Emery, Paul, J.E. Gottenberg, Andrea Rubbert‐Roth, et al.. (2014). Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. Annals of the Rheumatic Diseases. 74(6). 979–984. 112 indexed citations
11.
Mola, Emilio Martín, Alejandro Balsa, V. Martínez Taboada, et al.. (2014). Documento práctico para el uso de abatacept subcutáneo. Reumatología Clínica. 10(4). 218–226. 2 indexed citations
12.
Mola, Emilio Martín, Alejandro Balsa, V. Martínez Taboada, et al.. (2014). Practice Guidelines for the Use of Subcutaneous Abatacept. Reumatología Clínica (English Edition). 10(4). 218–226. 2 indexed citations
13.
Mola, Emilio Martín, Alejandro Balsa, V. Martínez Taboada, et al.. (2013). El uso de abatacept en artritis reumatoide: revisión de la evidencia y recomendaciones. Reumatología Clínica. 9(1). 5–17. 13 indexed citations
14.
Mola, Emilio Martín, Alejandro Balsa, V. Martínez Taboada, et al.. (2012). Abatacept Use in Rheumatoid Arthritis: Evidence Review and Recommendations. Reumatología Clínica (English Edition). 9(1). 5–17. 10 indexed citations
15.
García‐Vicuña, Rosario, Belén Padilla, Santiago Muñoz Fernández, et al.. (2009). Recomendaciones de manejo de la gripe A (H1N1) en pacientes reumáticos con inmunosupresión. Reumatología Clínica. 6(1). 63–68. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mieke F. Pouw Breakdown of academic impact, for papers by A. Sellas Breakdown of academic impact, for papers by Aleksander Lenert Breakdown of academic impact, for papers by J. Tébib Breakdown of academic impact, for papers by Bettina Bannert Breakdown of academic impact, for papers by À. Olivé Breakdown of academic impact, for papers by Víctor Martínez‐Taboada Breakdown of academic impact, for papers by William Ollier Breakdown of academic impact, for papers by Aideen Hogan Breakdown of academic impact, for papers by Tiziana Bertero
Rankless by CCL
2026